Bioalpha Holdings Berhad (KLSE:BIOHLDG)
Malaysia
· Delayed Price · Currency is MYR 0.0100
-0.0050 (-33.33%)
At close: Mar 9, 2026
Bioalpha Holdings Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 11.48 | 62.02 | 46.09 | 35.8 | 96.72 | Upgrade
|
| Revenue Growth (YoY) | -81.49% | 34.58% | 28.75% | -62.99% | 165.26% | Upgrade
|
| Cost of Revenue | 12.4 | 65.8 | 45.96 | 41.78 | 82.67 | Upgrade
|
| Gross Profit | -0.92 | -3.78 | 0.12 | -5.98 | 14.05 | Upgrade
|
| Selling, General & Admin | 22.66 | 42.06 | 43.89 | 31.86 | 18.94 | Upgrade
|
| Other Operating Expenses | 10.1 | 11.67 | 0.83 | 10.22 | -2.68 | Upgrade
|
| Operating Expenses | 32.76 | 53.73 | 44.72 | 42.08 | 16.26 | Upgrade
|
| Operating Income | -33.68 | -57.51 | -44.59 | -48.06 | -2.2 | Upgrade
|
| Interest Expense | -0.25 | -0.37 | -0.69 | -0.77 | -0.57 | Upgrade
|
| Earnings From Equity Investments | 0.03 | -0.06 | -0.01 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -33.89 | -57.93 | -45.28 | -48.83 | -2.77 | Upgrade
|
| Pretax Income | -33.89 | -57.93 | -45.28 | -48.83 | -2.77 | Upgrade
|
| Income Tax Expense | -4.02 | -1.6 | -1.63 | -0.04 | -1.25 | Upgrade
|
| Earnings From Continuing Operations | -29.88 | -56.34 | -43.65 | -48.79 | -1.52 | Upgrade
|
| Earnings From Discontinued Operations | -0.05 | 5.84 | - | - | - | Upgrade
|
| Net Income to Company | -29.93 | -50.49 | -43.65 | -48.79 | -1.52 | Upgrade
|
| Minority Interest in Earnings | 0.28 | 1.94 | 1.65 | 0.96 | 0.24 | Upgrade
|
| Net Income | -29.65 | -48.55 | -42 | -47.83 | -1.29 | Upgrade
|
| Net Income to Common | -29.65 | -48.55 | -42 | -47.83 | -1.29 | Upgrade
|
| Shares Outstanding (Basic) | 1,412 | 1,264 | 1,264 | 1,261 | 1,156 | Upgrade
|
| Shares Outstanding (Diluted) | 1,685 | 1,264 | 1,264 | 1,261 | 1,196 | Upgrade
|
| Shares Change (YoY) | 33.30% | - | 0.24% | 5.41% | 22.87% | Upgrade
|
| EPS (Basic) | -0.02 | -0.04 | -0.03 | -0.04 | -0.00 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.04 | -0.03 | -0.04 | -0.00 | Upgrade
|
| Free Cash Flow | -6.26 | -1.14 | -1.75 | -6.95 | -13.62 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | -7.98% | -6.09% | 0.27% | -16.71% | 14.53% | Upgrade
|
| Operating Margin | -293.29% | -92.71% | -96.76% | -134.26% | -2.28% | Upgrade
|
| Profit Margin | -258.23% | -78.28% | -91.13% | -133.62% | -1.33% | Upgrade
|
| Free Cash Flow Margin | -54.53% | -1.83% | -3.79% | -19.42% | -14.08% | Upgrade
|
| EBITDA | -28 | -49.8 | -36.88 | -39.21 | 6.59 | Upgrade
|
| EBITDA Margin | -243.87% | -80.29% | -80.02% | -109.54% | 6.82% | Upgrade
|
| D&A For EBITDA | 5.67 | 7.7 | 7.71 | 8.85 | 8.8 | Upgrade
|
| EBIT | -33.68 | -57.51 | -44.59 | -48.06 | -2.2 | Upgrade
|
| EBIT Margin | -293.29% | -92.71% | -96.76% | -134.26% | -2.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.